Development and implementation of cancer clinical trial patient screening using an electronic medical record-integrated trial matching system.

Nam Bui¹, Agnes Nika², Mateo Montoya³, Andrea Lopez², Jasmine Newman², Mounica Vaddadi⁴, Rahul Guli⁴, Melissa Rodin⁴, Ashley Robinson⁴, Eben Rosenthal⁵, Steven E Artandi², Sameer Ather³, Yi Pang², Joel Neal⁶

¹Stanford Cancer Institute, Stanford, California, USA nambui@stanford.edu.

²Stanford Cancer Institute, Stanford, California, USA.

³XpertDox, Birmingham, Alabama, USA.

⁴Stanford HealthCare Cancer Center, Stanford, California, USA.

⁵Vanderbilt University Medical Center, Nashville, Tennessee, USA.

⁶Department of Medicine, Stanford University, Stanford, California, USA.

PubMed PMC DOI PDF

Abstract

OBJECTIVES: Clinical trial enrolment is critical for the development and approval of novel cancer therapeutics, but patient identification and recruitment to clinical trials remains low and multiple trials accrue slowly or fail to meet accrual goals. Informatics solutions may facilitate clinical trial screening, ideally improving patient engagement and enrolment. Our objective is to develop and im…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.